Get complete Patent Opposition Report for Janssen Alzheimer Immunotherapy

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Janssen Alzheimer Immunotherapy's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP1793855Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1